Global Transcatheter Aortic Valve Replacement (TAVR) Market Report 2015 Edition: MarketResearchReports.Biz

Share Article has added a new research report on the "Global Transcatheter Aortic Valve Replacement (TAVR) Market Report 2015 Edition" to its collection. Explore All Medical Equipment Market Research Reports at

According to John Muir Health, an integrated healthcare system, around 50% patients suffering from severe aortic stenosis (AS) will not survive without an aortic valve replacement (AVR) for over two years after the onset of the symptoms. The need and demand for transcatheter aortic valve replacement (TAVR) in developed countries in the U.S. and Europe are fueling the growth of this market.

View Full Report at

TAVR is a recent development in the field of surgery and medical science. This technology is includes a minimally invasive procedure and is used to replace a constricted aortic valve. The procedure that deploys TAVR is also referred to as TAVI or aortic valve implantation. Aortic valve replacement generally requires open heart surgery. Hence, it is not suitable for patients who are at an increased risk for the process or too weak to opt for surgery. As a result of this, the demand for heart valve surgical procedures in the market is limited.

Download Detail Report With Complete TOC at

Factors Driving the Global TAVR Industry

WHO states that the aging of the world’s population in both developed and developing economies is an indicator that global health is improving. WHO forecasts that the world’s population of people of 60 years and older has doubled since 1980, and is going to cross the 2-billion mark by 2050. The increasing global aging population is one of the primary forces attributed to the growth of the TAVR market. Another important factor that is estimated to propel the TAVR market is the growing obese population. This trend will be witnessed more in the U.S. and other developed regions such as Europe and Japan. According to CDC, more than one-third of the adults in the United States are obese. The estimated annual medical cost of obesity in the United States was US$147 billion in 2008, and these costs were US$1,429 higher compared to those of normal weight. Some other factors that will fuel the growth of the global TAVR market are rising global healthcare expense and growing prevalence of patients not qualified for aortic stenosis surgery.

According to market analysts, the global transcatheter aortic valves market is worth billions and will demonstrate a promising growth of over 25% in the coming few years. Although the above TAVR market drivers will contribute to its growth, factors such as regulatory issues, associated high risks, and cost of TAVR devices will suppress the market.

Explore All Published Reports by same Publisher at

Some of the pioneers in the global TAVR market are Medtronic and Edwards Lifesciences. These two companies in the TAVR market operate in a highly dynamic industry scenario towards acquiring maximum share of the TAVR market.

About ( is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.

Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, has built a veritable reputation for fulfilling the most exacting market research needs.


State Tower
90 State Street,
Suite 700, Albany
NY 12207, United States
Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Browse Blog at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michell Thoras

Sheela AK
Follow us on
Visit website